Sort
261,768 grants matching “gene therapy”
Development of Tissue Engineered Tregs as a Treatment for Acute Ischemic Stroke
$1,150,417Payam Zarin · Gentibio, Inc. · R44 · FY2025 · NS
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform
$1,150,319Shawn Hingtgen · Univ Of North Carolina Chapel Hill · U01 · FY2022 · TR
An Avirulent Arthroconidial Vaccine Candidate to Prevent Human Coccidioidomycosis
$1,150,297John N Galgiani · University Of Arizona · R01 · FY2018 · AI
In Vivo Cellular and Molecular Imaging Centers (ICMICs)
$1,150,290Robert F Mattrey · University Of California, San Diego · P50 · FY2011 · CA
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
$1,150,263Jonathan P Schneck · Johns Hopkins University · P41 · FY2021 · EB
Finding Genes for Human Prostate Cancer
$1,150,252Elaine Ostrander · National Human Genome Research Institute · ZIA · FY2017 · HG
A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies
$1,150,207Jing Zhou · Isoplexis, Inc. · R44 · FY2021 · CA
A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies
$1,150,207Jing Zhou · Isoplexis, Inc. · R44 · FY2020 · CA
Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome
$1,150,123Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
MD Anderson Cancer Center SPORE in Head and Neck Cancer
$1,150,000Scott M Lippman · University Of Tx Md Anderson Can Ctr · P50 · FY2007 · CA
Development of a novel, targeted small molecule inhibitor of the nucleoside salvage pathway through combinatorial murine studies to enable further clinical advancement in prostate tumors
$1,150,000Kenneth Schultz · Trethera Corporation · R44 · FY2025 · CA
Nuclear Structure and Gene Expression
$1,150,000Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2006 · CA
SPORE in Lymphoma
$1,150,000Richard F. Ambinder · Johns Hopkins University · P50 · FY2007 · CA
INSPPIRE: A Longitudinal Cohort Study of Pediatric Chronic Pancreatitis to Predict Clinical Course and Identify Disease Modifiers
$1,149,999Aliye Uc · University Of Iowa · U01 · FY2022 · DK
STTR Phase II: Nanostraw-mediated Immune Cell Reprogramming
$1,149,998Ryan Swoboda · Navan Technologies Inc. · · FY2018 · TIP
An Avirulent Arthroconidial Vaccine Candidate to Prevent Human Coccidioidomycosis
$1,149,998John N Galgiani · University Of Arizona · R01 · FY2020 · AI
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models
$1,149,938John Peter Wikswo · Vanderbilt University · UH3 · FY2020 · TR
Pediatric Solid Tumor Microenvironment Atlas
$1,149,870Shahab Asgharzadeh · Children'S Hospital Of Los Angeles · U01 · FY2024 · CA
Biomedical Simulations Resource (BMSR)
$1,149,858David Z D'argenio · University Of Southern California · P41 · FY2010 · EB
A cross-species preclinical platform to enhance the translation of new medicines
$1,149,771Nicholas Andrew Geisse · Curi Bio Inc · R44 · FY2025 · TR
MOLECULAR THERAPY FOR RENAL DISEASE
$1,149,598Mount Sinai School Of Medicine Of Nyu · P01 · FY2000 · DK
Bay Area Team Against Resistance
$1,149,528Trever G Bivona · University Of California, San Francisco · U54 · FY2021 · CA
Dynamic State Space Modeling of Cancer Cell Response to Therapy
$1,149,496Garry P Nolan · University Of Southern California · U54 · FY2013 · CA
Preclinical optimization of a gene therapy for erythromelalgia and chronic pain
$1,149,467Fernando Aleman Guillen · Navega Therapeutics, Inc. · U44 · FY2023 · NS
Mouse Auditory Testing Core Facility
$1,149,414Tracy Fitzgerald · National Institute On Deafness And Other Communication Disorders · ZIC · FY2024 · DC